Clobetamil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Clobetamil

Quick Facts

Property Description
Active ingredient Clobetasol Propionate, Gentamicin
Form Topical formulation (Cream/Ointment)
Pharmacological class Super-high potency Corticosteroid & Aminoglycoside Antibiotic
Common use Intensive management of severe inflammatory skin conditions
Origin Synthetic (Glucocorticoid component)

What Pharmacological Class Does Clobetamil Belong To?

Clobetamil is classified as a combination topical drug containing a super-high potency synthetic glucocorticoid and an Aminoglycoside Antibiotic. This pharmaceutical identity stems from its two primary substances: Clobetasol Propionate, the potent corticosteroid component, and Gentamicin, the antibacterial agent. Pharmacological studies consistently recognize Clobetasol Propionate as belonging to the highest potency group of topical steroids, a characteristic differentiating it from medium or low-strength preparations often available over the counter. The drug is presented as a topical formulation, typically a cream or ointment, designed exclusively for external dermatological use in adult patients requiring intensive local treatment.

Clobetamil's Composition and Dual-Action Rationale

Clobetamil is a dual-active preparation, defined by the presence of Clobetasol Propionate for its anti-inflammatory properties and Gentamicin for its antibacterial effect. The synthetic nature of Clobetasol Propionate and the specific antibacterial action of Gentamicin characterize the formulation. This combination product differs from single-active-ingredient therapies by managing two critical therapeutic needs simultaneously: the underlying inflammatory response and the potential for a microbial complication. The strategic inclusion of Gentamicin is clinically supported when severe inflammatory skin conditions are known to be complicated by microbial presence.

What is the General Purpose of Clobetamil?

The general purpose of Clobetamil is the rapid and intensive control of severe inflammatory skin conditions that are susceptible to, or are already complicated by, bacterial infection. The drug’s powerful anti-inflammatory action rapidly suppresses the immune cascade that leads to prominent symptoms like redness and swelling, while also providing significant relief from associated pruritus (itching). Clobetasol Propionate is categorized as an essential medicine for managing corticosteroid-responsive dermatoses. Its overall function is to stabilize highly reactive dermatoses by powerfully interrupting the inflammatory cycle and ensuring the local microbial flora is managed.

Regulatory References

  1. Topical Corticosteroids - StatPearls - NCBI Bookshelf
  2. WHO Model Lists of Essential Medicines

What side effects are possible with Clobetamil?

Possible side effects and safety information

The officially documented safety profile for Clobetamil is governed by the presence of a super-high potency corticosteroid and an aminoglycoside antibiotic. The profile is defined by both local adverse reactions and the potential for systemic effects through absorption, as detailed in regulatory documents.

Local and Systemic Adverse Reactions

Side effects observed at the application site are the most frequently listed adverse events. These are officially classified as common and include burning, stinging, itching (pruritus), and local skin pain. Due to the high potency of the corticosteroid, structural changes in the skin such as skin atrophy, visible widening of blood vessels (telangiectasia), and stretch marks (striae) are also documented.

Systemic exposure to the corticosteroid component may lead to more clinically significant reactions classified as rare. These include suppression of the Hypothalamic-Pituitary-Adrenal (HPA) axis and, in rare instances, features of Cushing's Syndrome. These serious reactions are most commonly associated with prolonged exposure, application to extensive body surface areas, or use under occlusion.

Organ System and Population Safety Constraints

The regulatory safety notes identify specific organ systems involved. Beyond skin and endocrine effects, systemic absorption of the Gentamicin component carries a documented, though rare in topical use, risk for effects on the Ear and Labyrinth (ototoxicity) and Renal and Urinary systems (nephrotoxicity).

Pediatric patients are officially noted to be at a higher risk of systemic toxicity (HPA axis suppression) due to differences in skin surface area to body weight ratio. Furthermore, official labeling restricts the use of this high-potency product to short durations and explicitly excludes application to sensitive body areas such as the face, groin, or axillae.

Overdose and Emergency Response

Overdosage with Clobetamil is primarily associated with the systemic absorption of its super-high potency corticosteroid component following prolonged or excessive application. This systemic toxicity can lead to severe endocrine dysfunction. Documented manifestations of excess exposure include clinical signs resembling Cushing’s syndrome, alongside metabolic disturbances such as hyperglycemia and glucosuria.

The most serious regulatory concern is reversible HPA axis suppression, which carries the potential for life-threatening clinical glucocorticosteroid insufficiency if the drug is suddenly withdrawn. Urgent medical attention is required for the evaluation of these systemic effects. Regulatory guidance mandates that if HPA axis suppression is confirmed through laboratory testing, the drug should be gradually withdrawn or substituted with a less potent corticosteroid under medical supervision. If adrenal insufficiency is confirmed, supplemental systemic corticosteroids may be necessary.

Pediatric patients are uniquely susceptible to systemic toxicity, which can manifest as linear growth retardation and signs of intracranial hypertension. Although acute overdose from topical application is considered unlikely, any suspicion of overuse requires prompt professional medical evaluation.

Therapeutic Uses of Clobetamil

What Clobetamil Treats: Main Uses and Benefits

The primary therapeutic role of Clobetamil is relevant in clinical settings that involve acute or unstable symptom patterns, especially for short-term symptomatic assistance. The combination of active ingredients is commonly used to help manage symptoms related to inflammatory or irritative states and physical discomfort, particularly in conditions involving episodic or fluctuating manifestations.

This medication is applied across conditions presenting with acute or disruptive episodes, including severe forms of plaque psoriasis, recalcitrant eczema, and lichen planus. The corticosteroid component is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. This therapy generally helps address symptom clusters that may become intense or disruptive, such as pronounced redness, swelling, and excessive scaling.

A key benefit is commonly used to help with intense symptoms that create noticeable physiological strain, particularly severe pruritus (itching) and the associated discomfort. The composition is also considered relevant in clinical scenarios where the severe lesions are complicated by or susceptible to secondary bacterial infection, providing additional symptomatic assistance where microbial risk is present.

“It is relevant in situations requiring short-term symptomatic support and provides supportive relief from intense itching.”


Quick Fact: Supportive Management for Inflammation

Primary Use Focus Symptoms Managed (Examples) Patient Benefit Frame
Severe Inflammatory Flare-ups Pronounced redness, swelling, intense pruritus, scaling Supports improved day-to-day comfort and symptom stability
Bacterial Complication Risk Microbial presence in lesions, risk of infection escalation Assists with maintaining functional stability in compromised skin

Regulatory References

  1. NIH DailyMed Label

Eligibility and Restrictions for Use

The population eligibility for Clobetamil is strictly defined by regulatory authorities due to its super-high potency corticosteroid component. Use is primarily established for adult patients (18 years and older) requiring intensive topical treatment for corticosteroid-responsive dermatoses.

Absolute Contraindications

The medicine must NOT be used by any patient with a documented hypersensitivity to Clobetasol Propionate, Gentamicin, other corticosteroids, or any ingredient in the product. It is formally contraindicated for treating specific skin pathologies, including:

  • Rosacea
  • Perioral dermatitis
  • Acne vulgaris
  • Primary cutaneous viral infections (e.g., Herpes simplex)

Age and Use Restrictions

Clobetamil is not recommended for children under 12 years of age, as safety and effectiveness have not been established for this age group. The official label imposes strict anatomical limits, stating the product should not be used on the face, groin, or axillae (underarms). Use is also restricted in pregnant or nursing mothers, where its conditional use must be justified by the potential benefit outweighing the potential risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Clobetamil focuses on documented pharmacokinetic and pharmacodynamic interactions stemming from potential systemic absorption of its two active components.

Interaction Type Interacting Medicines / Class
Pharmacokinetic Strong CYP3A4 Inhibitors (e.g., Ritonavir, Itraconazole)
Pharmacodynamic Systemic Aminoglycosides (e.g., Tobramycin) and other Nephrotoxic or Ototoxic Drugs

Co-administration with strong CYP3A4 inhibitors may inhibit the metabolism of the Clobetasol Propionate component, potentially increasing its systemic exposure. This is a label-documented pharmacokinetic interaction.

Caution is noted regarding co-use with systemic aminoglycosides due to the possibility of cumulative toxicity from the Gentamicin component. This pharmacodynamic risk also extends to other agents classified as nephrotoxic or ototoxic.

Interaction-related toxicity risk from Gentamicin accumulation is specifically designated as elevated in patients with renal impairment. The regulatory documents state that interactions with food, alcohol, or herbal products are not established due to the topical administration route.

Mechanism of Action

Clobetamil is a synthetic corticosteroid which acts as an agonist for intracellular glucocorticoid receptors (GR)

. Upon binding, the activated drug-receptor complex translocates to the nucleus where it binds to specific glucocorticoid response elements (GREs) on DNA, regulating the transcription of anti-inflammatory and pro-inflammatory target genes.

This genomic action modulates the inflammatory signaling cascade primarily by inhibiting the synthesis and release of numerous chemical mediators, including prostaglandins, leukotrienes, and cytokines. This inhibition leads to a decreased capillary permeability, a reduction in vasodilation, and inhibited leukocyte migration to the site of action. Furthermore, Clobetamil modulates the gene expression of proteins associated with maintaining epithelial barrier function.

Dosage and Administration Information

How to Use Clobetamil

Clobetamil, a combination product containing Clobetasol Propionate and Gentamicin, is intended for topical administration only, in accordance with standards for super-high potency corticosteroids. The medication is applied as a thin layer to the affected area of the skin and gently rubbed in. It is not intended for use in the eyes, mouth, or other internal areas.

Official Usage Constraints

Usage parameters mandate strict limits on duration, frequency, and total dosage to control the potential for systemic exposure. Treatment is typically limited to one or two applications daily.

Usage Parameter Usage Guideline
Maximum Duration Generally limited to 2 consecutive weeks
Total Weekly Dose Should not exceed 50 grams in one week
Occlusion Use with occlusive dressings is prohibited unless medically directed

Administration Rules for Specific Areas

The application of Clobetamil must be avoided on highly sensitive areas of the body, including the face, groin, and axillae (underarms). This restriction is in place to manage absorption due to the high potency of the corticosteroid component. Use in pediatric patients under 12 years of age is generally not recommended, and if necessary, must be severely time-limited and carefully monitored. After application, hands should be thoroughly washed.

Recent Clinical Evidence

Research evidence / Overview of Studies for Clobetamil


Evidence Base for Severe Inflammatory Skin Conditions

The primary research for this medication focuses on its super-high potency corticosteroid component, which was studied for conditions characterized by periods of heightened symptoms, such as severe psoriasis and persistent eczema. The research mainly consists of short-term Randomized Controlled Trials (RCTs) where the active ingredient was evaluated in adult populations. These trials explored outcomes related to inflammatory or irritative states, observing how symptoms evolved in the observed populations compared to an inactive vehicle (a product base without the active drug).

Research examined measurements of overall clinical severity of the condition and focused on outcomes related to physical discomfort, particularly the intensity of redness, swelling, and patient-reported outcomes describing perceived discomfort like intense itching (pruritus). The findings describe patterns observed in the studies over the defined treatment intervals.


Research on Inflammatory Conditions with Bacterial Presence

The inclusion of an antibacterial component (Gentamicin) led to research being studied for skin conditions that may be complicated by or susceptible to bacterial involvement. Studies of this combination therapy were evaluated in research contexts involving fluctuating or unstable symptoms where a microbial presence was detected.

These combination studies monitored both the anti-inflammatory action and changes in the microbial presence at the lesion site. Studies reported that the addition of the antibacterial component was observed in some studies to be associated with changes in microbial patterns, contributing to the broader evidence landscape for dual-active topical preparations.


Long-Term Evidence and Research Gaps

Most clinical studies supporting the use of this medication focused on research exploring short-term symptom changes. As noted, the follow-up durations were limited to the specific period of active treatment, typically a few weeks. The short-term nature of these studies reflects that long-term effects are not fully established, and data are still emerging regarding the durability of these patterns.

Comparative evidence is lacking for directly positioning this specific Clobetasol Propionate/Gentamicin combination against all other available high-potency topical therapies for complicated skin conditions. Data for certain groups remain insufficient, especially for the general pediatric population and long-term, repeated use in older adults. Therefore, certainty remains low in areas outside the defined short-term usage in adult populations.

Key Studies & References

  1. DailyMed Label for Clobetasol Propionate
  2. WHO Model List of Essential Medicines (Corticosteroids, Topical)

Frequently Asked Questions (FAQ)

Common questions about Clobetamil (FAQ)


Q: What is the main difference between Clobetamil and other similar treatments?

Clobetamil is described in official classifications as a combination product because it contains two active ingredients: a super-high potency anti-inflammatory agent (Clobetasol Propionate) and an antibacterial agent (Gentamicin). This dual-active nature is the primary distinction that sets it apart from topical medications that typically contain only a single active ingredient.


Q: Is Clobetamil the same as Clobetasol?

No, Clobetasol Propionate is the name of the high-potency corticosteroid component found within Clobetamil. Clobetamil, as documented in product information, is a dual-active drug that contains both Clobetasol Propionate and Gentamicin, which is an antibacterial agent.


Q: Is it true that Clobetamil can thin the skin?

Official product information documents skin atrophy (thinning of the skin) as a possible local adverse reaction associated with Clobetasol Propionate, particularly with prolonged use. Other related structural changes, like visible blood vessels (telangiectasia) and stretch marks (striae), are also documented in the safety profile.


Q: What happens if I use Clobetamil for longer than intended?

Regulatory documents state that use is typically limited to a short duration, such as two consecutive weeks, because the drug is highly potent. Exceeding the recommended duration or dosage significantly increases the risk of serious systemic side effects due to increased absorption, such as the suppression of the HPA axis, which has been associated with complications like Cushing’s syndrome.


Q: Can using too much Clobetamil cause side effects?

Official labeling specifies strict limits on the maximum duration of use and total weekly dose to manage risk. Serious systemic reactions, such as the suppression of the body's internal hormone system (HPA axis), are generally associated with exposure that is prolonged or exceeds the recommended limits. These risks may include features of Cushing's syndrome.


Q: What should I look out for as a sign that Clobetamil is working?

Based on the indicated use, observed patterns in studies relate to the reduction of prominent symptoms, such as decreased redness, swelling, and patient-reported discomfort like intense itching. The drug is intended for the relief of inflammatory and pruritic manifestations of certain skin conditions.


Q: Can Clobetamil be used on broken or damaged skin?

Official information notes that when the skin’s barrier is compromised, such as by inflammation or other damage, the absorption of the corticosteroid component may increase. This elevated absorption raises the potential risk of systemic (body-wide) side effects, and official labels may restrict its use or note that absorption is increased if skin damage or atrophy (thinning) is already present.


Q: What are the official guidelines for stopping the use of Clobetamil?

Official product information states that therapy should be discontinued when the condition has been successfully brought under control. If signs of systemic effects like HPA axis suppression are documented, official product information describes protocols for discontinuation, such as gradually reducing the frequency of application or substituting a less potent corticosteroid.


Q: How long does the effect of Clobetamil last after stopping use?

Official documents indicate that the recovery of the body's hormone system (HPA axis) is generally prompt after the topical corticosteroid is stopped. The duration of how long the skin condition remains controlled after discontinuation is not defined as a specific time frame in official labeling, but treatment is intended to stop when the condition is controlled.


Q: Is it common for Clobetamil to cause headaches?

Headaches are not listed among the common local side effects observed at the application site. However, headaches have been reported in rare instances as a manifestation of intracranial hypertension, a rare systemic effect that has been linked to high systemic exposure to topical corticosteroids, particularly in the pediatric population.


Q: Is Clobetamil known to cause changes in mood?

Mood changes, such as depression or anxiety, are not listed as common side effects of Clobetamil. However, these symptoms have been associated with Cushing’s syndrome, which is a rare systemic reaction sometimes linked to prolonged exposure to high-potency corticosteroids.


Q: Does Clobetamil affect blood sugar levels?

Due to the systemic absorption of the corticosteroid component, manifestations of hyperglycemia (high blood sugar) and glucosuria (sugar in the urine) can be produced in rare instances. This is a potential, rare systemic effect that is generally associated with use that is prolonged or exceeds the recommended guidelines.


Q: Can Clobetamil interact with vaccines?

While the specific interaction is not detailed in all product labels, the corticosteroid component may theoretically affect the immune response when combined with live vaccines. Systemic absorption of the high-potency steroid is a topic sometimes discussed in relation to patients receiving vaccines.


Q: Does Clobetamil have known interactions with common multivitamins?

Official regulatory documents and labeling for Clobetamil state that interactions with common food, alcohol, or herbal products are not established. This conclusion is primarily based on the topical administration route and the limited amount of systemic absorption that typically occurs.


Q: Is Clobetamil known to interact with herbal supplements?

Official regulatory documents and labeling for Clobetamil state that interactions with food, alcohol, or herbal products are not established. This finding is generally attributed to the topical administration route and the typically limited systemic absorption of the drug.


Q: Does Clobetamil work for eczema?

Clobetamil is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Clinical research has examined conditions such as severe psoriasis and persistent eczema, studying outcomes related to these inflammatory states.


Q: Are there different strengths of Clobetamil available?

According to the dosage forms and strengths section of official labeling, the active ingredient, Clobetasol Propionate, is available in one common strength, 0.05%, across its various topical formulations (cream, ointment, etc.).

How should Clobetamil be stored and disposed of?

The official FDA and related regulatory labeling for the active ingredients in Clobetamil defines strict conditions for storage and disposal to maintain product integrity and ensure safety.

Official Storage and Environmental Conditions

Storage Requirement Official Regulatory Statement
Temperature Store at controlled room temperature, between 15 C and 30 C (59 F and 86 F) [1.1, 2.3].
Prohibited Environments Do not refrigerate and Do not freeze [1.1, 2.3].
Container & Protection Keep in the tightly closed, original container and protect from light [2.2, 2.6].
Child Safety Keep out of the reach of children [1.1].

Disposal Instructions

Unused or expired medicine must be disposed of in accordance with Federal, State, and local regulations [2.9].

Disposal should prioritize utilizing community drug take-back programs [2.4, 2.7]. If a take-back program is unavailable, follow the guidance to mix the medicine with an undesirable substance (such as coffee grounds), place it in a sealed container to prevent leakage, and then discard it in the household trash [2.4]. Do not flush the product down a toilet or pour it down a sink [2.4].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Clobetamil found in:

A-Z Index: